There is a lot to say.
Many, many of my sources and many US Senate staff and senators are eagerly awaiting news – from the Senate Congressman.
So let’s break down where we are right now. This weekend will be crucial for this bill. First, the votes on this bill, we expect the first tomorrow. It’s basically a motion to continue, to start the debate. We don’t know what time, somewhere tomorrow.
But in the meantime, the parliamentarian must weigh, because this bill goes through the process of budgetary reconciliation. In this process, in order to have this margin of 50 votes, no filibusters allowed, everything in this bill must have a primary budgetary effect. The parliamentarian decides whether to do so or not.
So what’s happening now is that every element of the bill is going through the parliamentarian, long meetings today. And I’m told that most people involved expect her to rule tonight. Now there are major climate and health provisions that are at issue that she will decide whether they stay in this bill or not, whether they can be accepted.
Judy, one of them is something that matters a lot to many Americans, the price of insulin. In this bill currently is a proposal to cap insulin at $35 for a monthly supply. We don’t know if this will pass. We’re looking at that tonight, but also that, many diabetics that we’ve talked to across the country.
And we spent time with them. And I want to take you and introduce you to a story that we did looking at how they see the potential impact of this bill in their lives, what it means.